Tania Small, GSK's VP, global head of oncology medical affairs and head of R&D diversity, equity and inclusion
June 30, 2022 01:42 PM EDTUpdated July 1, 09:11 AM
Pharma
Marketing

GSK se­lects ‘thought­ful’ mul­ti­ple myelo­ma pro­gram for in­au­gur­al ‘Think Tank’ chal­lenge win

Beth Snyder Bulik

Senior Editor

Jen­ny Ahlstrom is a mul­ti­ple myelo­ma pa­tient, founder of a non­prof­it group to help oth­er pa­tients and now a GSK in­no­va­tion chal­lenge win­ner.

Her or­ga­ni­za­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times